Compare IREN & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IREN | ZBH |
|---|---|---|
| Founded | 2018 | 1927 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.3B | 16.5B |
| IPO Year | 2021 | 2001 |
| Metric | IREN | ZBH |
|---|---|---|
| Price | $56.31 | $85.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 21 |
| Target Price | $62.50 | ★ $101.00 |
| AVG Volume (30 Days) | ★ 42.4M | 2.7M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | ★ 234.48 | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | $501,023,000.00 | ★ $8,231,500,000.00 |
| Revenue This Year | $104.58 | $4.96 |
| Revenue Next Year | $200.20 | $3.76 |
| P/E Ratio | ★ N/A | $69.74 |
| Revenue Growth | ★ 167.65 | 7.20 |
| 52 Week Low | $8.28 | $79.12 |
| 52 Week High | $76.87 | $108.29 |
| Indicator | IREN | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 47.97 |
| Support Level | $37.15 | $79.48 |
| Resistance Level | $64.60 | $102.52 |
| Average True Range (ATR) | 5.37 | 2.21 |
| MACD | -0.30 | 0.61 |
| Stochastic Oscillator | 53.54 | 76.73 |
IREN owns data centers powered by renewable energy in Canada and the US for bitcoin mining and AI cloud infrastructure. The company is in the process of converting its existing bitcoin capacity for AI purposes and securing new power and land supply to expand its data center operation. IREN works closely with industry leaders in AI, such as Microsoft, to support their cloud infrastructure ambitions.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.